Eurofins CDMO

@EurofinsCDMO

Early CDMO with services for human and veterinary pharmaceutical product development

International
Vrijeme pridruživanja: travanj 2014.

Tweetovi

Blokirali ste korisnika/cu @EurofinsCDMO

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EurofinsCDMO

  1. 16. lis 2019.

    CPhI is less than a month away and we’re getting ready to see you there! Meet us at booth ! Our BD team and Scientific/Technical team will be pleased to discuss about your API/DS/DP development needs. Schedule a meeting now:

    Poništi
  2. 19. ruj 2019.

    Our team is getting ready to meet you at CPhI Worldwide in Frankfurt, Germany! Join us at booth from November 5-7 to learn more about the vast number of services that Eurofins CDMO has to offer. Schedule a meeting today:

    Poništi
  3. 11. srp 2019.

    and are pleased to announce their collaboration to provide a global offer combining clinical study and supply chain activities. Our combined offer applies to biologics and small molecules in preclinical and early clinical phases.

    Poništi
  4. 10. srp 2019.

    We are becoming ! From July 1st, Eurofins Amatsigroup is renamed to fit with our global API/DS & DP offer. Visit our website:

    Poništi
  5. 28. svi 2019.

    @AmatsiGroup offers the design and of SEDDS based on pre-formulation solubility and phase-diagram studies to identify the most efficient self-emulsifying region. More information here: ]

    Poništi
  6. 17. svi 2019.
    Poništi
  7. 16. svi 2019.

    @AmatsiGroup provides in-house a full drug development package for all your preclinical, clinical and commercial needs in formulation and manufacturing for new small molecules and biologicals entities. Contact us:

    Poništi
  8. 2. svi 2019.

    Andrew Carver, Senior Business Development Manager @AmatsiGroup will attend the 16th Anglonordic Life Science Conference in London on May 9th. Contact us to set up a meeting:

    Poništi
  9. 30. tra 2019.

    Interested in what to look out for when choosing your biological compound’s development partner? Come to see our article on website:

    Poništi
  10. 22. ožu 2019.
    Poništi
  11. 14. ožu 2019.
    Poništi
  12. 5. ožu 2019.

    @AmatsiGroup is proud to announce that last Friday, Idron site dedicated to celebrated its 1000th batch produced. The team enjoyed this remarkable milestone around a friendly bowling contest. Congratulation to all

    Poništi
  13. 20. velj 2019.
    Poništi
  14. 21. pro 2018.
    Poništi
  15. 13. pro 2018.

    Carole Delauney, Senior Business Development Manager, is attending the Genesis Conference in London today! Come to meet us at Booth #3 for our CDMO services or contact us:

    Poništi
  16. proslijedio/la je Tweet
    28. stu 2018.

    Today, most biologics are administered parenterally. In the future, we will be able to take them orally. What a relief! Find out more about their future, here: @AmatsiGroup

    Poništi
  17. proslijedio/la je Tweet
    28. stu 2018.

    Nearly 3000 biological drugs are currently being developed. And the next big thing on the agenda? Find out in our brand spanking new Infographic! @AmatsiGroup

    Poništi
  18. proslijedio/la je Tweet
    29. stu 2018.

    In less than four years, 50% of drugs in sales will be biologics. How do we know? Download our brand new infographic and find out: @AmatsiGroup

    Poništi
  19. 28. stu 2018.

    Looking for quick-reading information on current trends in biologicals drug delivery? Check this:

    Poništi
  20. 27. stu 2018.

    Eurofins Amatsigroup (CDMO) provides custom made patient kits for clinical trials focused on Safety, Observance and Quality! Contact us for more information:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·